Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Officials warned residents and tourists packing Mediterranean destinations on Tuesday to stay indoors during the hottest hours as the second heat wave in as many weeks hits the region and Greece, Spain and Switzerland battled wildfires.
While the East Coast grappled with the aftermath of downpours that closed roads and rendered the water supply undrinkable in places, the West and other parts of the country contended with sizzling temperatures and unsafe air quality attributed to Canadian wildfires.
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
